ArticleJCO oncology practice2023

Clinical Administration Characteristics of Subcutaneous and Intravenous Administration of Daratumumab in Patients With Multiple Myeloma at Mayo Clinic Infusion Centers.

Scott A Soefje et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.